Content uploaded by Kenneth R Fox
Author content
All content in this area was uploaded by Kenneth R Fox on Oct 29, 2014
Content may be subject to copyright.
Exercise interventions for cancer patients: systematic review of controlled trials
Clare Stevinson
1,
*, Debbie A Lawlor
2
& Kenneth R Fox
1
1
Department of Exercise and Health Sciences, University of Bristol, Centre for Sport, Exercise and Health, Tyndall
Avenue, Bristol BS8 1TP, UK;
2
Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies
Road, Bristol BS8 2PR, UK
Received 16 April 2004; accepted in revised form 13 July 2004
Key words: cancer, rehabilitation, exercise, walking, fatigue.
Abstract
Objective: To systematically review controlled trials investigating the effects of exercise interventions in cancer
patients.
Methods: Studies were located through searching seven electronic databases (Medline, Embase, Cochrane Library,
CancerLit, PsycInfo, Cinahl, SportDiscus), scanning reference lists of relevant articles, contacting experts (n ¼ 20),
and checking the contents lists of journals available through ZETOC (Electronic Table of Contents). To be
included, trials had to be prospective, controlled, involve participants diagnosed with cancer and test an exercise
intervention. Types of outcome were not restricted. Two reviewers independently applied the selection criteria.
Results: Thirty-three controlled trials (including 25 randomized trials) were included in the review. There was some
evidence that physical function was increased among those who exercised. Furthermore, symptoms of fatigue did
not appear to be increased and there were few adverse effects reported. There was insufficient evidence to determine
effects on other outcomes, such as quality of life, with results hampered by the heterogeneity between studies as well
as poor methodological quality. Data were also lacking on the long term effects of exercise relating to cancer
recurrence or survival.
Conclusions: There is preliminary evidence that exercise interventions for cancer patients can lead to moderate
increases in physical function and are not associated with increased symptoms of fatigue. However, it is impossible
from current evidence to determine whether exercise has long term beneficial effects on survival or quality of life.
Introduction
Exercise has a role in the management or rehabilitation
of an increasing number of chronic diseases including
coronary heart disease [1], hypertension [2], stroke [3],
obesity [4], non-insulin dependent diabetes [5] and
musculoskeletal disorders [6]. Although it has also been
recommended for helping cancer patients recover from
treatment [7], exercise rehabilitation is not generally
incorporated into cancer care or discussed with patients
[8, 9]. Potential benefits of exercise include helping to
preserve or restore cardiopulmonary function, muscle
and bone strength, and mobility, all of which can be
adversely affected by cancer therapy. Furthermore,
exercise may help promote psychological well-being
following cancer diagnosis and treatment. Conversely,
there may be risks associated with exercise for cancer
patients, particularly possible exacerbation of fatigue –
an important symptom that affects more than half of all
patients to a significant degree [10].
Several reviews of the literature have suggested that
exercise is likely to be beneficial for cancer patients [11–
17]. However, in addition to not employing fully explicit
and systematic methods, these reviews have incorpo-
rated studies of various types including retrospective
surveys and uncontrolled trials. Clearer indications of
the effect of exercise interventions are provided by
prospective clinical trials with appropriate control
groups [18]. A recent systematic review in this area
identified 12 randomized trials and concluded that initial
* Address correspondence to: Clare Stevinson, Department of
Exercise and Health Sciences, University of Bristol, Centre for Sport
Exercise and Health, Tyndall Avenue, Bristol BS8 ITP, UK. Ph.: +44-
117-331-1108; Fax: +44-117-331-1148; E-mail: C.Stevinson@
bristol.ac.uk
Cancer Causes and Control 15: 1035–1056, 2004.
1035
Ó
2004 Kluwer Academic Publishers. Printed in the Netherlands.
evidence was promising for both physiological and
psychological benefits of exercise [19]. In a more
extensive search of the literature we have identified 25
randomized trials and eight non- randomized studies and
have performed a statistical synthes is of the data in
order to determine the effects of exercise in cancer
patients.
Materials and methods
Search strategy
The following electronic databases were searched from
their respective inceptions to December 2003: Medli ne,
Embase, Cochrane Controlled Trials Register, Cancer-
Lit, Cinahl, PsycInfo, SportDiscus. Search terms in-
cluded subject headings and text words based on (i)
cancer (e.g., neoplasms; tumour; oncology); (ii) exercise
(e.g., exercise therapy; physical activity; sports); (iii)
clinical trials (e.g. , controlled clinical trials; random) and
were modified according to the specific vocabulary map
of each database. In addition, a simple search of ‘cancer
AND (exercise OR physical activity)’ was set-up via
ZETOC (Electronic Table of Contents) of all British
Library journals, with results received in a daily e-mail
notification. Contact was made with 20 experts known
to be working in the field to ask if they were aware of
any further published or unpublished trials [20]. Finally,
the reference lists of review articles on the subject and
studies already located were checked for potential trials.
Titles and available abstracts of all items identified by
the electronic searches were scrutinized by one author
(CS) and a random selection of 25% of the titles/
abstracts was independen tly assessed by a second au thor
(DAL) to check for consistency in selection. A kappa
score of 0.95 was achieved. Obtained reports were read
by two reviewers (100% by CS and 50% each by DAL
and KRF) who independently applied the selection
criteria. The three authors then met to discuss any
disagreements and reach consensus.
Selection criteria
Trials were included if they involved human participants
who had been diagnosed with cancer. Participants could
be of any age, either sex, have any type or stage of
cancer or be at any stage of treatment or recovery. Only
prospective trials with a control arm were included.
Control arms could comprise no intervention (e.g.,
normal care), an alternative intervention (e.g. , counsel-
ing, relaxation) or a different exercise type (e.g., aerobic
versus flexibility exercises). Trials with healthy or his-
torical control groups were excluded. Non-randomized
trials were included as well as randomized ones. This
was an a priori decision made on the basis that the
number of randomized trials might be small and that it
was important to appraise all available evidence. Trials
were included if they tested interventions involving
regular exercise of any type (e.g., aerobic, resistance,
flexibility). Exercise could be the sole intervention or
combined with other interventions (e.g., diet, counsel-
ing). Trials of single exercise sessions that measured
acute effects (e.g., [21]) were excluded, as were trials that
only investigated the effects of physiotherapy (e.g., [22]).
There were no restrictions on the outcomes assessed in
trials. Both published and unpublished trials written in
any language, in full or abstract form were considered
for inclusion.
Data extraction
Included trials were read in full and data were
extracted by two reviewers (100% by CS and 50%
each by DAL and KRF) using a pre-piloted struc-
tured form. Any disagreements or discrepancies were
resolved throu gh discussion and checking the original
papers. Details on the study design, participants,
interventions, outcome measures, results and conclu-
sions were recorded. Where key information was not
reported, efforts were made to contact the authors in
order to obtain further de tails.
Quality assessment
In the absence of validated methods of assessing
methodological rigor suitable for trials of exercise
interventions, trial quality was assessed by recording
whether the following features were incorporated in the
study design: randomization; allocation concealment;
blinding of the main outcome assessment and inten-
tion-to-treat analysis. These have been identified as the
most important components in minimizing bias in
clinical trials [23]. Trials were defined as randomized if
the method of allocating participants to intervention
and control groups was described using terms such as
random, randomly or randomization. Allocation con-
cealment was considered adequate if randomization
took place at a remote site or involved drawing sealed
sequentially numbered envelopes. Trials were defined
as blind if the main outcomes were measured by an
assessor who was blind to group allocation. If the main
outcomes were measured by a non-blinded assessor or
by the participants themselves as with self-report
questionnaires, the trial was defined as not blind.
Trials were defined as using intention-to-treat analysis
1036 C. Stevinson et al.
if all patients were analysed in the groups to which
they were allocated, regardless of completion or
adherence. Studies described as using intention-to-treat
analysis that excluded participants not completing the
intervention, were recorded as not using intention-to-
treat analysis.
Data analysis
Included trials were summarized in tables and de-
scribed in the text. After completion of this descriptive
synthesis we examined the data to determine whether
there were areas where statistical pooling would be
possible. This was determined on the basis of having at
least four studies in a similar population group with a
similar outcome. On this basis we were able to examine
the effect of exercise on physical functioning in patients
with breast cancer and also examine the same outcome
in a separate pooling of studies that had included
patients with any cancer diagnosis. In addition we
performed a third meta-analysis of trials (irrespective
of cancer type) with fatigue as an outcome. Cancer-
related fatigue has been identified as an important
outcome and has the potential to be either reduced or
increased through exercise. It was considered appro-
priate therefore to try to quantify this possibility. For
each outcome (physical function and fatigue) effect
sizes were calculated for each trial using Cohen’s
method [24] to produce a standardized mean difference
for the effect of exercise. It was anticipated that there
would be systematic differences (heterogeneity) be-
tween the results of studies and a random effects model
using DerSimonian and Laird’s [25] method was used
to calculate the pooled effect size. Hete rogeneity
between studies was further explored using meta-
regression analysis to determine the role of trial type
(randomized or not), allocation concealment, blinding
of outcome assessment , intention-to-treat analysis and
cancer type (for the fatigue meta-analysis only) on
difference between studies [26]. Funnel plots were
examined and statistical evidence of small study bias
(indicative of publication bias) was assessed with Egger
and Begg tests [26]. All analyses were undertaken using
Stata version 8 [26].
Results
Figure 1 shows the outcome of the search process. From
the 80 reports of potential trials that were located, 40 did
not meet the eligibility criteria [27–66], and a total of 33
studies reported in 40 different papers were included in
the review [67–106]. Data were pooled for 19 trials that
assessed physical functioning and 12 trials that assessed
fatigue.
Trial characteristics
Table 1 shows the characteristics of included trials.
Thirteen trials included breast cancer patients during
[67, 70, 72, 74, 76, 77, 79–81], or after [68, 71, 73, 75]
adjuvant therapy. Eleven trials involved adult patients
with any cancer [85, 87, 90–93, 95–97, 99, 100] and
one involved paediatric cancer survivors [94]. The
remaining trials included patients undergoing treat-
ment for prostate [82–84], lung [104], colorectal [101],
or stomach [105] cancer, multiple myeloma [102] or
leukemia [106]. Nineteen studies tested aerobic exercise
interventions, of which eight used cycle ergometers
[68, 77, 79-81, 93, 96, 105], and eight used walking
programs [70, 71, 73, 74, 76, 85, 91, 95]. Three trials
tested resistive exercise [82, 83, 106], 10 had combined
aerobic and resistive programs [67, 75, 84, 86, 92, 97,
99, 100, 103, 104] and one study was based on team
sport activities [94]. Most trials compared an exercise
intervention with no intervention; six that did not,
used information training [84], psychological therapies
[85, 92], stretching [70, 88], or tai chi [71] as
comparison arms. Exercise interventions lasted for
10 weeks or longer in 17 trials [67, 68, 72, 73, 76, 77,
79–83, 85, 87, 90, 94, 101, 102], between 4 and
8 weeks in 12 trials [70, 71, 74, 75, 84, 91, 92, 95, 97,
99, 100, 106], and 2 weeks or less in four studies [93,
96, 104, 105]. The longest intervention period of any
trial was 26 weeks [72].
Methodological quality
Table 2 shows the methodological features of included
trials. In general, studies were of poor quality. There
were eight trials not using randomized allocation [73,
80, 81, 86, 93–95, 99], and of the 25 that did, only five
indicated that concealment of allocation may have been
adequate [68, 82, 92, 102, 104]. Two studies appeared to
include participants in the control group who had
declined to undertake the intervention [94, 99], and for a
further five studies it was unclear whet her eligibility
(including willingness to participat e) was determined
prior to group allocation or whether the control gro up
may have solely or partly consisted of those who
declined to be allocated to exercise [73, 80, 81, 88, 95].
Assessor blinding for a main outcome measure took
place in two trials [68, 100]. In 13 studies, the main
outcome measure was completed by the participant, so
blinding was not possible [72, 73, 79, 83–85, 92, 93, 97,
99, 101, 102, 104]. The other 18 trials for which assessor
Exercise for cancer patients 1037
blinding was possible, either did not use blinding [67,
96], or did not state if the assessor was blind to the
allocation group [70, 71, 74–77, 80–82, 87, 90, 91, 94,
95, 105, 106]. Four studies analysed data on an
intention-to-treat basis [69, 72, 83, 99]. In six other
papers intention-to-treat analysis was described [68, 85,
92, 93, 96, 101], but not all the allocated participants
were included in the analysis. Other methodol ogical
limitations that were common among included trials
were small sample sizes and multiple statistical testing.
Only eight trials had more than 30 participants per
group, [72, 83–85, 92, 97, 101, 104], and 14 trials had 10
or fewer subjects [67, 71, 73, 75, 76, 80–82, 87, 90, 91,
94, 100, 106]. Sample sizes were based on power
calculations in only nine trials [67, 68, 72, 74, 83, 85,
89, 94, 104], with two failing to recruit the required
number [67, 89], and a further trial reported an
insufficient sample size from a post hoc power calcula-
tion [106]. Seventeen trials did not specifically state the
primary outcome measures [70, 73, 74, 76, 84, 87, 90–94,
97, 99, 100, 102, 104, 106], and even among those that
did, there were several with numerous secondary out-
come measures and sub-group analyses. With many
questionnaire measures having additional subscales and
with measurements taken at multiple time-points, some
studies involved considerable numbers of statistical
comparisons [68–70, 72, 76, 82–89, 91, 94, 97, 99, 101,
106]. Conclusions were commonly based on isolated
positive findings (those with a p-value below the
conventional 0.05 level), while the role of chance as an
explanation for these and results with higher p-values,
was disregarded.
Trial outcomes
Physical function
Thirteen trials reported small but statistically signifi-
cant improvements in tests of aerobic capacity [68, 70,
77, 80, 81, 88, 90, 95, 100] or timed walk distances
[67, 74–76] following aerobic exercise programmes
lasting from 6 to 25 weeks. In one study, loss of
physical performance was attenuated among inpatients
80 papers reporting trials considered for inclusion
37 excluded
- 26 had no control group [29-54]
- 5 were abstracts duplicating data from full papers [55-59]
- 2 were not of prospective design [60, 61]
- 2 included non-cancer patients [62, 63]
- 1 had inadequate control group [64]
- 1 provided no data from control group [65]
2 unable to be traced [27, 28]
41 papers reporting trials meeting inclusion criteria
1 excluded during data extraction
- 1 data not analyzed according to group allocation [66]
40 papers included reporting a total of 33 trials [67-106]
10 trials assessing physical
function in breast cancer
patients included in statistical
analysis [67, 68, 70, 72, 74-
77, 80, 81]
9 trials assessing physical
function in patients with any
cancer included in statistical
analysis [85, 88, 90, 91, 94-
97, 99]
12 trials assessing fatigue in
cancer patients included in
statistical analysis [67, 68,
70, 74, 80, 82, 83, 85, 93, 97,
99, 101]
Fig. 1. Process of study selection.
1038 C. Stevinson et al.
Table 1. Characteristics of controlled clinical trials of exercise interventions for cancer patients
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Breast cancer
Campbell et al. [67]
United Kingdom
Breast cancer patients
receiving adjuvant
therapy [22/19]
(1) Supervised group
aerobic and
resistive exercise
(2) Usual care
2 days per week
for 12 weeks
QoL (FACT-B);
physical function
(12-min walk test);
fatigue (PFS)
Group 1 increased
distance walked
by 333 m more
than group
2(p = 0.001)
‘exercise may
be a safe and
effective way of
improving the
QoL for patients
with early stage
breast cancer’
All outcomes
favoured
intervention
group but study
lacked power
Courneya et al. [68]
Fairey et al. [69]
Canada
Post-menopausal breast
cancer survivors
(average 14 months
post-treatment) [53/52]
(1) Supervised
aerobic cycle
ergometer training
(2) Usual care
3 days per week
for 15 weeks
Physical fitness
(VO
2
max); QoL
(FACT-B);
fasting insulin;
other outcomes
included fatigue,
body composition,
insulin resistance,
IGFs
Group 1 improved
VO
2
by 0.29 l/min
more than group 2
(p < 0.001) and
also improved
more on overall
and physical QoL,
fatigue, self-esteem,
happiness; but not
body composition
or fasting insulin
‘beneficial effects
on cardiopulmonary
function and QoL’ ...
‘no significant effect
on fasting
insulin... effects
on IGF-I, IGFBP-3
... clinical impli-
cations remain to
be defined’
Suggests
improvements
in fitness,
fatigue and
some
psychosocial
outcomes are
possible after
treatment; no
clear effects on
insulin or insulin
resistance
Drouin [70]
United States
Breast cancer
patients receiving
radiation therapy
[23/21]
(1) Unsupervised
walking
(2) Stretching
3–5 days per week
for 7 weeks
Physical function
(VO
2
peak); muscle
strength
(dynamometry);
body composition
(calliper); fatigue
(PFS); immune
function
Group 1 improved
VO
2
by 2.0 ml/kg/min
more than group 2
(p = 0.014);
other outcomes
not different
between groups
‘exercise training
is means to improve
physical function and
body composition...
immune parameters
and oxidative stress
values were not
compromised’
Suggests that
fitness enhance-
ment is possible
during radia-
tion therapy
Galantino et al. [71]
United States
Breast cancer
survivors [11/8]
(1) Tai chi classes
and video
(2) Walking and
stretching classes
1 day per
fortnight for
6 weeks
Physical function
(6-min walk test);
body mass index;
QoL (FACT-B);
fatigue (BRI)
No differences
between groups
on any outcomes
‘study supports the
need for further
research on the effect
of alternative forms
of exercise to
manage fatigue’
Study design
and size
precludes
determination of
relative benefits
of interventions
Segal et al. [72]
Canada
Breast cancer
(stage I–II) patients
receiving adjuvant
therapy [123/123]
(1) Supervised
gym-based walking
(2) Unsupervised
home-based
walking
(3) Usual care
5 days per week
for 26 weeks
Physical functioning
(SF-36); other
outcomes included
QoL, aerobic
capacity,
body weight
Group 2 increased
perceived physical
functioning
more than group
3; other outcomes not
different between
groups
‘exercise can
blunt some of the
negative side
effects of treatment,
including reduced
physical functioning’
Well-designed
trial with no
consistent effect
among multiple
outcomes
measured
Exercise for cancer patients 1039
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Segar et al. [73]
United States
Breast cancer survivors
(average 3.5 years
post-surgery) [30/24]
(1) Unsupervised gym
or home-based aerobic
activity
(2) Aerobic activity plus
behaviour modification
(3) No intervention
4 days per week
for 10 weeks
Depression (BDI);
anxiety (SSTAI);
self-esteem (RSEI)
Group 1 and 2
combined in
analysis; lower
depression, state
& trait anxiety
than group 3;
no change
in self-esteem
‘exercise may be
of therapeutic
value with
respect to
depressive and
anxiety symptoms
but not to
self-esteem’
Aspects of
study design
and analysis
preclude
interpretation
of data
Mock et al. [74]
United States
Breast cancer (stage
I or II) patients
undergoing radiation
therapy [50/46]
(1) Unsupervised
home-based walking
(2) Usual care
4–5 days per week
for 6 weeks
Physical function
(12-min walk
test); fatigue (PFS);
symptoms (SAS)
Group 1 improved
distance walked 87 m
more than group
2(p = 0.003) and
had lower symptom
intensity for fatigue,
anxiety and sleep
‘walking program
can help manage
symptoms and
improve physical
function during
radiation therapy’
Implies possible
small effect on
symptom
severity but re-
sults may reflect
baseline
differences
Nieman et al. [75]
United States
Breast cancer survivors
(average 3 years
post-diagnosis) [16/12]
(1) Supervised weight
training and aerobic
activity
(2) No intervention
3 days per week
for 8 weeks
Change in NK
cell cytotoxic
activity; physical
performance
(6-min walk test)
Group 1 improved
distance walked 59 m
more than group 2
(p = 0.02); no change
in NK cell activity
in either group
‘moderate exercise
over 8-week period
has no significant
effect on in vitro NK
cells in breast
cancer patients’
Suggests no ef-
fect on NK cell
activity in recov-
ered patients
Mock et al. [76]
United States
Breast cancer (mostly
stage II) patients
receiving
chemotherapy [19/14]
(1) Unsupervised
home-based walking
(and weekly support
group)
(2) Usual care
4–5 days per week
for 4–6 months
Physical function
(KPS; 12-min
walk test);
pyschosocial
adjustment (PAIS;
BSI); body
image (VAS; TSCS);
symptoms (SAS)
Group 1 increased
distance walked by
58 m more than
group 2 (p < 0.05);
also superior
psychosocial
adjustment,
body image and
symptom tolerance
during treatment
but not post-test
‘physical and
psychosocial benefits
from a modest walking
program and support
group are possible’
Implies possible
role in symptom
management but
caveats exist due
to inclusion of
support group
and baseline dif-
ferences
MacVicar et al. [77]
Winningham et al. [78]
United States
Breast cancer
(stage II) patients
receiving
chemotherapy [62/45]
(1) Supervised aerobic
cycle ergometer training
(2) Stretching and
flexibility once a week
(3) Usual care
3 days per week
for 10 weeks
Functional capacity
(VO
2
max); body
weight and
composition (for
sub-group of 24
non-obese patients)
Group 1
improved
VO
2
> 0.4 l/min
than groups 2 and 3
(p < 0.05) and
also gained 2.7%
less fat and 3.3kg
more lean tissue
than group 3
‘intervention effective
in improving functional
capacity’ .. . ‘potential
for stabilizing weight
as well as reducing
fat deposition’
Suggests that
beneficial effects
on fitness and fat
distribution are
possible
during therapy
1040 C. Stevinson et al.
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Winningham
and MacVicar . [79]
United States
Breast cancer (stages
II–IV) patients
receiving
chemotherapy [42/42]
(1) Supervised aerobic
cycle ergometer training
(2) Stretching and flexibil-
ity once aweek
(3) Usual care
3 days per week
for 10 weeks
Nausea, somatization
(SCL-90-R)
More from group 1
(n = 8) improved
on nausea ratings
than group 2 and 3
(p = 0.03) and also
overall somatisation
‘moderate aerobic
exercise may provide
some relief from nausea
in select patients’
Suggests
potential
anti-nausea
effect
MacVicar and
Winningham
[80]
United States
Breast cancer patients
receiving
chemotherapy [10/10]
(1) Supervised
aerobic cycle
ergometer training
(2) Usual care
3 days per
week for 10 weeks
Functional capacity
(VO
2
peak); mood
(POMS)
Group 1 improved
VO
2
by 0.38 l/min
more than group 2
and also improved
more on mood
but group differences
not analysed
‘small sample size
precludes definitive
conclusions... trend
toward improved mood
warrants further study’
Reported
findings
may reflect
selection
bias and
regression to
mean
Winningham [81]
United States
Breast cancer
(stage II) patients
receiving
chemotherapy [8/8]
(1) Supervised
aerobic cycle
ergometer training
(2) Usual care
3 days per week
for 10 weeks
Functional capacity
(maximum
estimated METs);
perceived
control (LLC)
Group 1 increased
functional capacity
by 0.8 METS more
than group 2 and
also greater increase
in perceived control
but group differences
not analysed
‘patients improved in
functional capacity as
result of participation
in program’
Indicates the
feasibility of
exercise
programmes for
cancer patients
Prostate cancer
Oliver [82]
United Kingdom
Prostate cancer
patients receiving
androgen deprivation
therapy [10/9]
(1) Supervised
resistive training
(2) Usual care
3 days per week
for 12 weeks
Body composition
(DEXA and BIS);
other outcomes
included physical
function, fatigue
and QoL
Group 1 increased
appendicular lean
mass by 1.2 kg
and total lean mass
by 2.3 kg more
than group 2 (p = 0.02)
‘resistive training is
an effective adjunct
treatment of cachexia
in prostate patients
on androgen
deprivation therapy’
Suggests that
muscle wastage
is reversible.
All outcomes
favoured
exercise group
but study
lacked power
Segal et al. [83]
Canada
Prostate cancer
patients receiving
androgen deprivation
therapy [155/155]
(1) Supervised
resistive training
(2) Usual care
3 days per week
for 12 weeks
Fatigue (FACT-F);
QoL (FACT-P);
other outcomes
were muscular
fitness and body
composition
Group 1 improved
more on fatigue,
QoL and muscular
fitness than group 2;
no differences for
body composition
‘resistive exercise
reduces fatigue and
improves QoL and
muscular fitness’
Well-designed
study
suggests that
small
benefits in some
areas are
possible
Berglund
et al. [84]
Sweden
Prostate cancer
patients – 60%
on active
treatment [211/115]
(1) Supervised group
physical training
(2) Group information
class once a week
(3) Combined group
physical and information
training once a week
(4) No intervention
1 day per week
for 7 weeks (plus
1 booster session
after 2 months)
Perceived benefits of
programme
(questionnaire)
Group 3 perceived
greater relaxation
when sitting and
breathing than
group 1; satisfaction
was higher in group
3 than 1 or 2; no
assessment of group 4
‘benefit of certain
aspects of the
physical program
is greater in the
combination group
than physical
training alone’
Suggests that
multi-faceted
interventions are
preferred
by patients
Exercise for cancer patients 1041
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Mixed cancers
Courneya et al. [85]
Canada
Cancer patients
(breast; colon; ovarian;
stomach etc.) – 56%
completed treatment
[108/96]
(1) Unsupervised
home-based walking
(and weekly group
psychotherapy)
(2) Group
psychotherapy
weekly
3–5 days per
week for
10 weeks
QoL (FACT-G);
other outcomes
included life
satisfaction,
depression, anxiety
fatigue, fitness,
body composition
Group 1 improved
more than group 2
on functional QoL;
also fatigue and body
composition; prior
exercise was higher
in group 1
‘program may improve
QoL in cancer survivors
beyond the benefits
of group psychotherapy,
particularly physical
and functional
well-being’
Suggests possible
effect of
exercise on
functional out-
comes that are
not addressed by
psychotherapy
Hayes et al. [86, 87]
Hayes et al. [88, 89]
Australia
Cancer patients after
receiving high dose
chemotherapy and
autologous peripheral
blood stem cell
transplantation [12/12]
(1) Aerobic and
resistive gym-based
training
(2) Stretching
3 days per week
for 12 weeks
Aerobic capacity
(VO
2
peak); muscular
strength (gym tests);
QoL (CARES);
body composition
(total body water);
immune function
Group 1 improved
VO
2
by 7.8 ml/kg/
min more than
group 2 (p <0.05);
also improved more
on upper and lower
body strength and
QoL; no different
for immune
parameters or body
composition
‘patients able to regain
fitness & strength’ ...
‘reduction in number
and severity of
problems’ ... ‘preserve
and increase skeletal
mass’ ... ‘did not
facilitate faster
immune cell recovery’
Most outcomes
favour exercise
group but base-
line differences
and small sam-
ple hinder inter-
pretation
Burnham and Wilcox
[90]
United States
Cancer patients (breast;
colon) P 2 months
post-treatment [21/18]
(1) Supervised
gym-based low-
intensity aerobic
training
(2) Super-
vised gym-based
moderate-intensity
aerobic training
(3) No intervention
3 days per week
for 10 weeks
Aerobic capacity
(VO
2
max); flexibility
(sit and reach test),
body composition
(calliper); QoL
(QLICP)
Groups 1 and 2
combined in the
analysis; improved
VO
2
4.6 ml/kg/min
more than group 3
(p < 0.05) and also
improved more on
body fat, flexibility,
QoL
‘low and moderate
intensity programs
were equally effective in
improving physiological
and psychological
function’
Implies low and
moderate inten-
sity exercise
produced
similar effects
on fitness, but
sample size may
have been
insufficient to
detect
differences
Mello et al. [91]
Brazil
Cancer patients
receiving bone marrow
transplants [32/18]
(1) Supervised walk-
ing on treadmill
and stretching (2)
Usual care
Once daily for
6 weeks
Muscle strength
(dynamometry)
Group 1 increased
hip flexor strength
on non-dominant
side more than
group 2. Other
muscle groups not
different.
‘exercise program was
efficient in promoting
an increase of muscle
strength’
Walking and
stretching
programme had
little effect on
muscle strength
1042 C. Stevinson et al.
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Petersson et al. [92]
Sweden
Cancer patients (breast,
colon, prostate)
within 3 months of
diagnosis [442/325]
(1) Supervised
group physical
training (and infor-
mation, education,
cognitive behavi-
oural therapy)
(2) Individual support
(3) Combination
of interventions
1 and 2
(4) Usual care
1 day per week
for 8 weeks
(plus 1 booster
session after
2 months)
Depression (HAD);
anxiety (HAD);
subjective
distress (IES)
No differences between
group 1 and 3 compared
with 2 and 4 on
depression or anxiety.
Avoidance reduced in
group 1 in breast
patients who were
’monitors’ and
increased in prostate
patients who were
’blunters’
‘only the monitor
concept
seems useful for
predicting response to
rehabilitation with
a strong information
component’
No apparent ef-
fect of exercise
component on
psychological
outcomes
beyond
psychotherapy
Dimeo et al. [93]
Germany
Cancer patients (mostly
breast) receiving
high-dose chemotherapy
and autologous
peripheral blood stem-cell
transplantation [62/59]
(1) Supervised aerobic
training on supine
cycle ergometer in bed
(2) Usual care
Once daily during
hospitalization
Psychologic status
(POMS; SCL-90-R)
Group 1 reduced global
psychological distress
while group 2 did not
change, but no group
differences analysed
‘aerobic exercise can
reduce fatigue and
improve psychologic
distress’
Implies that
slight improve-
ments in
psychological
well-being may
be possible
Niesen-Vertommen
[94] Canada
Paediatric cancer
survivors (average
5 years post-treatment)
[20/18]
(1) Supervised group
sports (soccer, hockey,
basketball etc)
(2) No intervention
3 days per week
for 12 weeks
Pulmonary function
(FVC); aerobic
fitness (Vo
2
max);
self perceptions
(SPPC)
Group 1 no different
to group 2 for any
outcomes
‘exercise program did
not demonstrate a
difference in exercise
tolerance’
Exercise may
not have been
sufficient for
fitness change
Dimeo et al. [95]
Germany
Cancer patients
(mostly breast) just
completed high-dose
chemotherapy and
autologous peripheral
blood stem-cell
transplantation [36/32]
(1) Supervised walking
on treadmill
(2) Usual care
Once daily for
6 weeks
Physical performance
(maximum speed
on treadmill test);
other outcomes
included
haemoaglobin levels
and fatigue
Group 1 improved
speed by 0.72 km/h
more than group 2
(p = 0.04);
haemoaglobin increased
by 1 g/dl (p = 0.04);
4 patients in group 2
reported fatigue in
performing daily
activities
‘aerobic exercise
improves the physical
performance of cancer
patients recovering
from high-dose
chemotherapy’
Suggests that pa-
tients can
exercise and
improve fitness
after high-dose
chemotherapy
Dimeo et al. [96]
Germany
Cancer patients (mostly
breast) receiving
high-dose chemotherapy
and autologous
peripheral blood
stem-cell transplantation
[70/60]
(1) Supervised interval
training on supine
cycle ergometer
30 minutes daily
(2) Usual care
During
hospitalization
( 2 weeks)
Loss of physical
performance
(maximum speed
on treadmill test);
other outcomes
included
haematologic indices
and treatment
complications
Group 1 decreased
speed by 0.37 km/hour
less than group 2
(p = 0.05), was
hospitalised for 1.6 days
less (p = 0.03), had
less pain and diarrhoea
and shorter periods of
neutropenia
and thrombopenia
‘aerobic exercise can be
safely carried out
immediately after
high-dose
chemotherapy and
can partially prevent
loss of physical
performance’
Implies possible
effect in
partially
preserving
fitness during
high-dose
chemotherapy
Exercise for cancer patients 1043
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Berglund et al. [97]
[98] Sweden
Cancer patients (mostly
breast) within 2 months
of completing
treatment [199/176]
(1) Supervised group
physical training (and
information and coping
skills for 7 weeks)
(2) No intervention
1 day per week
for 4 weeks
Problems with
physical activity,
symptoms, QoL
(questionnaire)
Group 1 improved
more than group 2
on perceived physical
strength post-test and
3, 6, 12 months later;
also physical training
post-test, 3 and
12 months and fighting
spirit at post-test, 6 and
12 months, but had
poorer baseline scores
‘results demonstrate
several short-term
effects’ ... ‘programme
seems to be successful
with respect to patients’
fighting spirit, physical
strength and training as
late as 1 year after’
Intervention had
no effect on most
of the outcomes
measured (>70)
Berglund et al. [99]
Sweden
Cancer patients (mostly
breast) within 2 months
of completing
treatment [60/60]
(1) Supervised group
physical training (and
information and coping
skills for 7 weeks)
(2) Usual care
1 day per week
for 4 weeks
Problems with
physical activity,
symptoms, QoL
(questionnaire)
Group 1 improved
more than group 2
on physical and
social activities and
physical strength
‘participants improved
more on physical
strength and increased
physical training and
social activities more’
No effect
reported for
most of the
outcomes
measured;
(> 60) poor
(p < 0.05), but for
most outcomes had
poorer scores before
and throughout 1 year
of follow up
compliance and
exercise only
one component
Beuttner and
Gavon [100]
United States
Cancer survivors within
5 years of diagnosis
[18/17]
(1) Supervised group
aerobic/strength training
(2) No intervention
3 days per week
for 8 weeks
Fitness (estimated
VO
2
, heart rate,
strength, flexibility);
personality (C16PFQ)
Group 1 improved all
aspects of fitness
and some of
personality, but group
differences not
analysed
‘program was sufficient
for improvements in
physical fitness’
Suggests fitness
improvements
are possible in
cancer survivors
Other cancers
Courneya et al. [101]
Canada
Colorectal cancer
patients following
surgery [102/93]
(1) Unsupervised
aerobic exercise
2) Usual care
3–5 days per week
for 16 weeks
Quality of life
(FACT-C); other
outcomes included
life satisfaction,
depression, anxiety
fatigue, fitness,
body composition
No differences between
groups on any outcomes;
reported levels of
exercise similar
between groups
‘increased
cardiovascular
fitness is associated with
improvements in QoL’
High levels of
exercise in con-
trol group may
have masked
effects of inter-
vention
1044 C. Stevinson et al.
Table 1. Continued.
Author
Location
Participants
[Number
allocated/analysed]
Intervention and
control arms
Frequency and
duration
of exercise
Main endpoints Reported results Authors conclusion Reviewers
comments
Coleman et al.
[102, 103]
United States
Multiple myeloma
patients receiving
high-dose chemotherapy
and autologous
peripheral stem-cell
transplantation [24/17]
(1) Unsupervised
home-based aerobic
and resistive training
(2) Usual care (including
advice to walk for
20 minutes 3 days per
week)
5 days per week for
12 weeks pre and
post transplant
Fatigue, sleep; other
outcomes included
aerobic capacity,
strength, body
composition, mood
Group 1 gained lean
body tissue compared
with group 2; no
differences in
other outcomes
‘patients can
maintain or
improve fitness
levels’ ...
‘exercise
program is
feasible and
may be effective for
decreasing fatigue and
mood disturbance
and improving sleep’
Most outcomes
favoured group
1, but substan-
tial amounts of
missing data
from analysis
preclude inter-
pretation
Wall [104]
United States
Lung cancer patients
about to undergo
surgery [104/97]
(1) Unsupervised
pre-operative aerobic,
resistive and breathing
home-based exercises
once daily
(2) No intervention
Once daily for
1 week pre-surgery
Hope (HHI);
power (PKPCT-VII)
Group 1 increased
power more than group
2; no different on hope
‘exercise is a form of
knowing participation
in change’
Importance of
outcomes for pa-
tients unclear
Na et al. [105]
South Korea
Stomach cancer patients
undergoing surgery
[35/32]
(1) Supervised aerobic
exercise on arm and
cycle ergometers in bed
twice daily (2) Usual care
5 days per week
for 2 weeks
Change in NK cell
cytotoxic activity
Group 1 increased
NK cell cytotoxic
activity more
than group 2
‘early moderate exercise
has beneficial effect
on function of in vitro
NK cells after
curative surgery’
Implies exercise-
induced immu-
nologic change
following sur-
gery
Cunningham et al.
[106] United States
Acute leukaemia
patients receiving bone
marrow transplant
[40/30]
(1) Supervised resistive
exercises
(2) Supervised resistive
exercises 5 days per week
(3) Usual care
3 days per week
for 5 weeks
Body composition
(skinfolds); muscle
protein (nitrogen
balance; creatinine
excretion)
Group 1 maintained
creatinine status
while group 3
decreased, but group
differences not analysed;
no differences in
other outcomes
‘lack of physical
activity appears
to have a negative
influence on
maintenance of muscle
protein, but results are
not conclusive’
Implies possible
sparing of
muscle protein
through exercise
but not
clearly
demonstrated
Notes. QoL: quality of life; FACT-B: Functional Assessment of Cancer Therapy – Breast; PFS: Piper Fatigue Scale; IGF: (insulin-like growth factor); SF-36: Medical Outcomes Survey –
Short Form-36; BDI: Beck Depression Inventory; SSTAI: Spielberger State Trait Anxiety Inventory; RSEI: Rosenthal Self-Esteem Inventory; SAS: Symptom Assessment Scale; NK:
natural killer; KPS: Karnofsky Performance Scale; PAIS: Psychosocial Adjustment to Illness Scale; BSI: Brief Symptom Inventory; VAS: visual analogue scale; TSCS: Tennessee Self-
Concept Scale; SCL-9-R: Derogatis Symptom Check List – 90-Revised; POMS: Profile of Mood States; METs: metabolic equivalents; LLC; Levenson Locus of Control; DEXA: dual
energy X-ray absorptiometry; BIS: bioelectrical impedance spectroscopy; FACT-F: Functional Assessment of Cancer Therapy – Fatigue; FACT-G: Functional Assessment of Cancer
Therapy – General; QLICP: Quality of Life Index for Cancer Patients; CARES: Cancer Rehabilitation Evaluation System; HAD: Hospital Anxiety and Depression scale; IES: Impact of
Event Scale; FVC: forced vital capacity; SPPC: Self-Perception Profile for Children; C16PFQ: Cattell’s Sixteen Personality Factor Questionnaire; HHI: Herth Hope Index; PKPCT-VII:
Power as Knowing Participation in Change Test, version II.
Exercise for cancer patients 1045
Table 2. Methodological features of included trials
Author Randomized allocation Concealment of allocation Assessor blinding for
main outcomes
Intention-to-treat analysis
for main outcomes
Other aspects
Breast cancer
Campbell et al. [67] Yes – computer
generated number
Not stated No No – 3 not included Sample size calculation indicated
insufficient power for main QoL
outcome
Courneya et al. [68]
Fairey et al. [69]
Yes – random number table Yes – sealed envelopes
prepared by person not
involved with allocation
Yes for fitness &
blood tests; No for
self-report QoL
No for fitness &
QoL – 3 not included; Yes
for insulin – last value
carried forward
Sample size calculation reported but
lacking details; multiple outcomes
assessed
Drouin et al. [70] Yes – random number table Not stated Not stated No – 2 not included Baseline differences existed
Galantino et al. [71] Yes – random number table Not stated Not stated No – 3 not included
Segal et al. [72] Yes – random numbers table No No – self-report measure Yes Multiple outcomes assessed; baseline
differences existed
Segar et al. [73] No – rotated sequentially No No – self report measures No – 6 not included Only half of sample included in
results
Mock et al. [74] Yes – random for 1st patient
then alternate
No Not stated No – 4 not included Lack of outcome data
provided; baseline differences existed
Nieman et al. [75] Yes – no detail Not stated Not stated No – 4 not included Sample size may have lacked power;
baseline differences
existed
Mock et al. [76] Yes – cluster randomized
– no further detail
Not stated Not stated No – 4 not included Baseline differences existed
MacVicar et al. [77]
Winningham et al. [78]
Yes – stratified on
aerobic capacity – no
further detail
Not stated Not stated No – 17 not included Lack of outcome data
provided
Winningham and
MacVicar [79]
Yes – no detail Not stated No – self report measure Not stated – no
dropouts reported
Lack of outcome data
provided
MacVicar and
Winningham [80]
Not stated Not stated Not stated Not stated – no
dropouts reported
Baseline differences existed
Winningham et al. [81] No – based on ability
to attend exercise sessions
No Not stated Not stated – no
drop-outs reported
Baseline differences existed
Prostate cancer
Oliver et al. [82] Yes – computerized
random number table
Yes – sealed envelopes
prepared by individual
not connected with study
Not stated No – 1 not included Sample size may have lacked power;
multiple outcomes assessed
Segal et al. [83] Yes – random number table Not stated No – self-report measures Yes Sample size calculation indicated
adequate power for main outcome
measures
Berglund et al. [84] Yes – no detail Not stated No – self report measure No – 96 not included
1046 C. Stevinson et al.
Table 2. Continued.
Author Randomized allocation Concealment of allocation Assessor blinding for
main outcomes
Intention-to-treat analysis
for main outcomes
Other aspects
Mixed cancers
Courneya et al. [85] Yes – random numbers
table – cluster randomized
No No – self report measure No – 12 not included Multiple outcomes assessed
Hayes et al. [86, 87]
Hayes et al. [88, 89]
No – matched groups Not stated Not stated No – 2 not included
for some variables
Sample size calculation
reported for some variables but
lacking details; baseline differences
existed; multiple outcomes assessed
Mello et al. [91] Yes – no details Not stated Not stated Not stated – no drop
outs reported
Lack of outcome data provided
Burnham et al. [90] Yes – stratified on
aerobic capacity &
QoL – no further details
Not stated Not stated No – 3 not included Three groups collapsed into 2 for
analysis; baseline differences existed
on some variables
Petersson et al. [92] Yes – no detail Yes – performed by
statistics unit
No – self report No – 117 not included Four groups collapsed into 2 for
analysis
Dimeo et al. [93] No – based on date of
hospitalisation
No No – self report measures No – 3 not included No inter-group analysis
Niesen-Vertommen
et al. [94]
No – based on ability
to attend exercise sessions
No Not stated No Power calculation reported but lack-
ing details; baseline differences
existed
Dimeo et al. [95] No – based on living
close to facility
No Not stated No – 4 not included
Dimeo et al. [96] Yes – no detail Not stated No – but yes for some
secondary outcomes
No – 10 not included Multiple outcomes assessed
Berglund et al. [97, 98] Yes – Efron biased coin
method for small samples
Not stated No – self-report measures No Baseline differences existed on some
variables; multiple outcomes
assessed
Berglund et al. [99] No – matched control
group selected from those
declining intervention
No No – self-report measures Yes Baseline differences existed on some
variables; multiple outcomes
assessed
Beuttner and
Gavon [100]
Yes – drawing names
without replacement
No Yes No – one not included Lack of outcome data available
Other cancers
Courneya et al. [101] Yes – random number table Not stated No – self-report measure No – 9 not included
Coleman et al.
[102, 103]
Yes – computerized
randomization
Yes – sealed envelopes
prepared by research
assistant
No – self report measures
but yes for some other
outcomes
No – 14 not included Lack of outcome data provided;
much missing data
Wall et al. [104] Yes – no detail Yes – sealed envelopes
prepared by statistics unit
No – self-report measures No – 7 not included Sample size calculation reported but
lacking details
Na et al. [105] Yes – no detail Not stated Not stated Not – 3 not included Lack of outcome data provided
Cunningham et al.
[106]
Yes – computer
generated number
Not stated Not stated No – 10 not included Post hoc calculation indicated insuf-
ficient power; baseline differences
Exercise for cancer patients 1047
receiving high-dose chemotherapy who exercised dur-
ing hospitalization [96]. Increases in muscular strength
were recorded after resistive training schedules in three
trials [82, 83, 88]. Six other studies reported no
differences in fitness parameters [71, 72, 94, 101, 102]
or muscle strength [70, 91] following aerobic exercise
programmes.
Figure 2 shows the effects of exercise on physical
function in 10 trials of breast cancer patients (Figure 2a)
and 9 trials of trials that recruited patients with any cancer
(Figure 2b). For both groups of patients there was some
evidence that exercise improved physical function. For
trials that recruited patients with breast cancer the pooled
standardized mean difference suggeste d that those who
Fig. 2. (a) Effects of exercise on physical function in controlled trials recruiting patients with breast cancer [n ¼ 10]; (b) Effects of exercise on
physical function in controlled trials recruiting patients with any cancer [n ¼ 9].
1048 C. Stevinson et al.
exercised had on average a 0.96 (95% CI: 0.49, 1.43)
standard deviation greater physical function than those
who did not. However, there was heterogeneity between
studies (p ¼ 0.001), which was not explained by whether
the trial was randomized (p ¼ 0.8), whether there was
allocation concealment (p ¼ 0.5), blinding of the outcome
assessment (p ¼ 0.5) or whether there was adequate
description of the control group such that it was clear
controls were eligible participants (p ¼ 0.2). Only one
study used intention-to-treat analysis and analysis type
was a source of heterogeneity (p ¼ 0.001). It should be
noted from Figure 2a that the largest study [72], which
was also the only study to use intent ion-to-treat analysis,
found no effect of exerci se on physical function. There was
no evidence of small study bias in this meta-analysis (p-
values for Beggs and Egger test both > 0.5). For trials
that recruited patients with any type of cancer the pooled
standardized mean difference suggested that those who
exercised had on average a 0.55 (95% CI: 0.12, 0.97)
standard deviation greater physical function than those
who did not. However, there was considerable heteroge-
neity also between these studies (p < 0.001), which was
mainly due to one small trial that was not randomized, did
not blind the outcome assessment and did not undertake
intention-to-treat analysis. With this study removed, the
pooled standar dized mean difference suggested that those
who exercised had, on average, a 0.26 (95% CI: 0.03, 0.50)
standard deviation greater physical function than those
who did not, and there was no heterogeneity between the
remaining studies (p ¼ 0.19). It should also be noted that
two of the largest trials [85, 97], both of which were
randomized, showed no effect of exercise on physical
function. There was evidence of small study bias in this
meta-analysis (both Beggs and Egger test p-value ¼ 0.01
with all studies included, and p ¼ 0.07 Beggs, and p ¼ 0.04
Egger, when the small heterogeneous study was re-
moved).
Fatigue
Reductions in cancer-related fatigue were reported in 10
studies [67, 68, 74, 76, 80, 82, 83, 85, 93, 95], although in
three of them, statistical significance was not reached
[67, 82] or not tested for [93]. No differences between
groups were reported for fatigue in six trials immediately
after the intervention or several months later [70, 71, 97–
99, 101, 102]. Pooling the data from 12 trials that
assessed fatigue suggested that there was no overall
effect of exercise on symptoms of fatigue: mean stan-
dardized difference ) 0.15 ()0.38, 0.09) standard devia-
tion (Figure 3). Heterogeneity between studies
Fig. 3. Effects of exercise on symptoms of fatigue in any cancer trials [n ¼ 12]
Exercise for cancer patients 1049
(p < 0.001) was not related to randomization (p ¼ 0.16),
allocation concealment (p ¼ 0.65), intention-to-treat
analysis (p ¼ 0.42) or choice of control (p ¼ 0.16).
However, the effect did appear to vary by population
type (p ¼ 0.04), with some evidence that in trials that
recruited patients with any type of cancer [85, 93, 97, 99]
finding no effect of exercise on fatigue symptoms: 0.04
()0.26, 0.35) and those that recruited patients with
breast cancer [67, 68, 70, 74, 80] suggesting a modest
reduction in sympt oms of fatigue among those allocated
to exercise: )0.52 ()0.95, )0.09) standard deviation.
There was no strong evidence of small study bias in this
meta-analysis (Beggs and Egger test both
p-values >0.1).
Body composition
Decreases in skinfold measurements without simulta-
neous reductions in total body weight were reported in a
trial of non-obese breast cancer patients undergoing
chemotherapy [78], suggesting that fat mass had been
replaced by muscle tissue. Similar findings were reported
in two other studies involving breast cancer patients [85,
90]. Increased lean body weight was reported in a trial of
patients with multiple myeloma [102], and reductions in
body weight and fat mass were described in a sample of
breast cancer patients receiving radiation therapy [70].
Appendicular and total lean mass were increased in
prostate cancer patients receiving androgen deprivation
therapy [82]. Six other studies reported no changes in
body weight [72, 86], or skinfold measurements [68, 83,
101, 106]. Changes in muscle protein status of leukemia
patients receiving marrow transplants could not be
clearly demonstrated [106].
Other physiological parameters
Natural killer cell activity was increased among post-
operative stomach cancer inpatients exercising with bed
ergometers for 2 weeks [105], but was unchanged in
recovered breast cancer survivors following 8 weeks of
exercise [75]. T-cell numbers and function were not
changed by exercise after high-dose chemotherapy and
stem-cell transplantation [87]. No alterations to immune
parameters or oxidative stress were observed during
exercise in breast cancer patients receiving radiation
therapy [70]. In another study of inpatients exercising
with bed ergometers while undergoing high-dose che-
motherapy and stem-cell transplantation, no changes in
haemoglobin or haematocrit were reported [96], but
among patients having completed the same treatment,
haemoglobin increased by 1 g/dl following a six week
walking programme [95]. Fasting insulin, glucose and
insulin resistance were not changed by a 15 week
training programme in breast cancer survivors [69].
Testosterone and prostate-specific antig en levels of
prostate cancer patients did not differ between those
following a resistive exercise programme and the control
group [83].
Treatment-related symptoms
Sleep problem s were reduced in two studi es of breast
cancer patients [74, 76], while there was a trend
towards improved sleep in a trial of patients with
multiple myeloma [103]. Decreased nausea was de-
scribed in one trial of breast cancer patients [79], but
did not differ to the control group in another [76].
Lower severity of treatment-related pain and diar-
rhoea was reported for inpatients receiving high-dose
chemotherapy in one study [96]. In a further trial, no
differences in frequency and burden of sympt oms were
reported following exercise, information and coping
skills training [97].
Psychosocial outcomes
Increases in global quality of life measures were
reported in four trials [67, 68, 83, 89], while five
other studies did not demonstrate significant differ-
ences between exercise and control groups [71, 72, 97,
99, 101]. Improvements in specific quality of life
dimensions of functional [85] and physical [68] well-
being were also reported.
Beneficial effects on depression were reported in
three studies [72, 73, 76], but not in five others [74, 92,
97, 99, 101]. Anxiety was reduced in two trials [73,
74], but not in five others [76, 92, 97, 99, 101]. A
further trial did not find additional effects of a
walking programme on depression, anxiety or other
psychological outcomes beyond those provided by
psychotherapy [85].
One study reported enhanced self-esteem [68], but
three others did not [72, 73, 76]. In two trials, body
image remained higher for exercisers during [76] and
after [74] treatment than for co ntrol participants, but no
differences in body image were reported in two other
studies [97, 99]. Reported reductions in global psycho-
logic distress [93] and changes in psychosocial adjust-
ment to illness and emotional distress [76] during
treatment favoured exercise groups.
Adherence
Adherence to exercise interventions was reported to be
over 70% in 19 studies [67, 68, 70, 72–76, 82–86, 90, 93,
94, 96, 102, 104]. One trial repo rted poor compliance
with 20% of the sample attending no more than one
exercise session [99]. In another study, 51% of the
control group reported exercising to the prescribed
1050 C. Stevinson et al.
intervention level, meaning that average level of activity
did not differ between groups [101]. Nine of the
remaining trials that did not report ad herence, involved
exercise interventions that were supervised by study
personnel [77, 79, 80, 92, 95, 97, 100, 105, 106].
Tolerability
Adverse events were reported in four trials. Lymp he-
dema (n ¼ 3), influenza and a gynecological complica-
tion were reported among participants from the exercise
group, while bronchitis and a foot fracture were
reported in participants from the control group in a
study with post-menopausal breast cancer survivors [68] .
A trial involving patients with multiple myeloma
reported no injuries but one patient broke a central
venous catheter stitch [102]. Shoulder tendonitis oc-
curred in one breast cancer patient who reportedly
exceeded the exercise prescription of the study [70].
Muscle and joint stiffness (n ¼ 5) were reported from the
control group in a trial of leukemia patients undergoing
bone marrow trans plant [106]. Nine studies reported
that no adverse events occurred [67, 72, 74–76, 89, 90,
95, 96], while no mention of adverse events was made in
the remaining 20 trials [65, 71, 73, 77, 79–83, 85, 91–94,
97, 99–101, 104, 105].
Discussion
A total of 33 controlled trials were identified, with
studies of breast cancer patients being most common.
There was some evidence of improved physical func-
tion due to exercise among patients with breast cancer
or those with any type of cancer, although the larger
and better quality trials tended to report null effects
with this outcome. For other outcomes, including
quality of life and psychological symptoms, there was
no clear or consistent evidence that exercise was
beneficial with trials having conflicting results. We
found no evidence that exercise resul ted in increased
fatigue symptoms in patients with cancer. All of these
findings need to be treated with caution be cause of
heterogeneity between studies and methodological lim-
itations. Finally, there is no evidence from clinical trials
with which to determine the effect of exercise on long
term outcomes relating to cancer recurrence or sur-
vival.
Methodological issues
Comprehensive search procedures were adopted when
locating studies for this review in the attempt to limit the
impact of publication and reporting bias [107]. These
can result from the tendency for trials not showing
positive results to remain unpublished [108], take longer
to reach publication [109], or be published in non-
English language journals [110]. Furthermore, coverage
bias in the non-indexing of a number of European
journals in major literature databases has been reported
[111]. The comprehensive search procedures used in this
review contributed to the inclusion of 13 studies that
have not been reported in previous reviews of the
literature.
Conclusions of any review are dependent on the
quality of the included studies. Although there are signs
in this review that this is improving, with some of the
more recent trials demonstrating the greatest rigor [69,
72, 82, 83, 104], most trial findings must be interpreted
with caution because of methodological limitations.
Although the majority of trials were randomized, very
few described using an adequate method of allocation
concealment. Both inadequate methods of generating,
and concealing, allocation sequences are prone to
selection bias and associated with overestimations of
the value of interventions [112, 113]. Double blinding is
not possible with behavioural interventions such as
exercise. However, few of the trials that measured
objective endpo ints reported blinded assessment, which
increases the risk of biased assessment and exaggerated
treatment effects [112]. Few studies analysed data on an
intention-to-treat basis meaning that the advantages of
randomization are lost and estimates of efficacy may be
inflated [114]. Many of the studies in the review had only
small samples, few of which were based on sample size
calculations. Differential outcomes between groups in
trials with small samples are more likely to be due to
chance [115] leading to a false-positive result (type-I
error). Conversely, small samples may lack sufficient
power to detect significant differences between interven-
tion groups even if they exist, creating a false-negative
finding (type-II error). Multiple outcomes measurement
and sub-group analyses were undertaken in many trials.
This raises the possibility that significant results
reported for one outcome among many others in a
single study, are due to chance [116, 117].
Effects of exercise
There was some evidence of improvements in physical
function. Minimizi ng loss of physical function during
treatment and regaining it afterwards, are important for
patients in terms of facilitating activities of daily living.
Prolonged inactivity following surgery and adjuvant
therapy exacerbates physical debilitation leading to
increased fatigue with even minor exertion. Graded
Exercise for cancer patients 1051
exercise interventions have therefore been recommended
for breaking the vicious cycle that can develop between
inactivity, physical deconditioning, and fatigue [118].
There is evidence that patients undergoing adjuvant
therapy, as well as those who have completed treatment,
were able to maintain a regular exercise programme
without experiencing major adverse effects or increased
fatigue. As is always the case with clinical trials, results
may only apply to carefully screened patients who are
sufficiently motivated to consent to participate. Within
wider clinical practice, uptake and adherence to exercise
programmes and physical limitations of patients may be
more problematic than for participants in the studies
reviewed.
For other outcomes it was not possible to elucidate
any clear or consistent effects of exercise. There was
considerable heterogeneity between studies in terms of
participant, intervention and outcome variables and
many methodological weaknesses, all of which may
contribute to the inconsistencies among results.
Future directions
One of the purposes of conducting systematic reviews in
newly developing research fields is to identify and
acknowledge the deficiencies in the literature in order
to stimulate further and better research in the future
[119]. There are currently several important gaps in the
evidence base.
Patient groups
Although a number of trials have focused on patients
with breast cancer, there are few studies on the other
three most common cancers – colorectal, lung and
prostate. It is not always appropriate to generalize
findings from one cancer population to another due to
the major differences in disease-related factors, treat-
ment regimes and patient demographics.
Outcome measures
A large number of outcomes were assessed in some trials
with primary endpoints rarely defi ned. The most impor-
tant outcomes for cancer patients relate to recurrence of
disease, survival, quality of life and ability to perform
activities of daily living. Since studies to date have
tended to assess outcomes at the end of the exercise
intervention only (rather than longer term follow-up),
there is current ly no evidence from clinical trials of the
effect of exercise on disease recurrence or survival. For
quality of life and functional abilities, studies should aim
to use the same standardized measures so that findings
are comparable. Furthermore, it is essential to
pre-define main outcome and the magnitude of a
clinically important effect for all measures, rather than
simply report statistically significant differences based
on arbitrary p-values.
Intervention components
There is so far little evidence to help identify the
optimum mode, frequency, intensity and duration of
activity required for beneficial effects in cancer popula-
tions. Existing attempts to compare low versus moderate
intensity activity [90], or gym versus home-based exercise
[72] have not produced clear findings. A staged
approach may be helpful in addressing these issues such
as the framework proposed by the Medical Research
Council Health Services and Public Health Research
Board in the UK for the development and evaluation of
complex health interventions [120].
Methodological design
There are multiple methodological weaknesses among
existing studies. Randomization, allocation conceal-
ment, blinded assessment, intention-to-treat analysis
and sample size calculations are all essential for clinical
trials of effectiveness. Other design considerations
include the choice of comparison arms in order to
control for spontaneous improvements over time and
the contextual aspects of an interventi on (i.e. , additional
contact with researchers and other participants). Fur-
thermore, studies combining and comparing exercise
with other interventions (e.g., support groups; psycho-
therapy) will help determine how best to integrate
rehabilitation strategies to address the full range of
needs of patients. Finally, continuing to monitor
patients beyond the end of the structured intervention
is essential for establishing the long term effects of
interventions in promoting sustained physical activity,
increasing survival, preventing recurrence and enhanc-
ing quality of life.
Conclusion
From a critical evaluation of data currently available
from controlled trials, it appears that cancer patients
can benefit from improved physical function without
increases in fatigue associated with exercise. It is
impossible to determine from current evidence whether
exercise has direct effects on survival, recurrence or
quality of life.
Nonetheless, on the basis of the rationale for exercise
during cancer rehabilitation and prelimina ry findings
from existing studies, further research of this subject is
encouraged.
1052 C. Stevinson et al.
Acknowledgements
We thank the following investigators for providing
information on study sources and/or additional infor-
mation about their work: L Buettner (Florida Gulf
Coast University), G Berglund (Uppsala University), A
Campbell (University of Glasgow), E Coleman (Uni-
versity of Arkansas for Medical Sciences), K Courne ya
(University of Alberta), A Daley (Sheffield Hallam
University), F Dimeo (Freiburg University Medical
Centre), J Drouin (University of Michigan-Flint),
E Durak (Medical Health & Fitness), S Hayes (Queens-
land University of Technology), S Macora (University
of Wales – Bangor), A Morgan (Fred Hutchinson
Cancer Research Centre), N Mutrie (University of
Glasgow), S Oliver (University of Wales – Bangor),
L-M Petersson (Uppsala University), D Porock (Uni-
versity of Missouri-Columbia), A Schwartz (Oregen
Health Services University), R Segal (Ottawa Regional
Cancer Centre), M Segar (University of Michigan), B
Stoll (St Thomas’ Hospital), P Swan (Arizona State
University).
Funding: Clare Stevinson is funded by Cancer
Research UK [CUK] grant number C3875/A3887.
Debbie A Lawlor is funded by a UK Department of
Health Career Scientist Award. The views expressed in
this paper are those of the authors and not necessarily
those of any funding body.
Conflicts of interest: None
References
1. Jolliffe J, Rees K, Taylor RS, Thompson D, Oldridge N, Abrahim S
(2004) Exercise-based rehabilitation for coronary heart disease
[Cochrane Review]. The Cochrane Library Issue 2. Oxford: Update
Software.
2. Pescatello L, Franklin, BA, Fagard R, Farquhar WB, Kelley GA,
Ray CA, American College of Sports Medicine (2004) American
College of Sports Medicine position stand. Exercise and hyper-
tension. Med Sci Sports Exerc 36: 533–553.
3. Gordon N, Gulanick M, Costa F, et al., American Heart
Association Council on Clinical Cardiology, Subcommittee on
Exercise, Cardiac Rehabilitation, and Prevention; the Council on
Cardiovascular Nursing; the Council on Nutrition, Physical
Activity, and Metabolism; and the Stroke Council (2004) Physical
activity and exercise recommendations for stroke survivors.
Stroke 35: 1230–1240.
4. Jakicic J, Clark K, Coleman E, et al., American College of Sports
Medicine (2001) American College of Sports Medicine position
stand. Appropriate intervention strategies for weight loss and
prevention of weight regain for adults. Med Sci Sports Exerc 33:
2145–2156.
5. Albright A, Franz M, Hornsby G, et al. (2000) American College
of Sports Medicine position stand. Exercise and type 2 diabetes.
Med Sci Sports Exerc 32: 1345–1360.
6. Vuori I (2001) Dose-response of physical activity and low back
pain, osteoarthritis, and osteoporosis. Med Sci Sports Exerc 33:
S551–S586.
7. Schneider C, Dennehy C, Carter S (2003) Exercise and Cancer
Recovery. Champaign, IL: Human Kinetics.
8. Jones L, Courneya KS (2002) Exercise discussions during cancer
treatment consultations. Cancer Pract 10: 66–74.
9. Stevinson C, Fox K (2004) Role of exercise for cancer rehabil-
itation in UK hospitals: a survey of oncology nurses. Eur J Cancer
Care (in press).
10. Curt G (2001) Fatigue in cancer. BMJ 322: 1560.
11. Smith S (1996) Physical exercise as an oncology nursing inter-
vention to enhance quality of life. Oncol Nurs Forum 23:
771–778.
12. Thune I, Smeland S (2000) Is physical activity important in
treatment and rehabilitation of cancer patients? [Norwegian].
Tidsskr Nor Laegeforen 120: 3302–3304.
13. Pinto B, Maruyama NC (1999) Exercise in the rehabilitation of
breast cancer survivors. Psychooncology 8: 191–206.
14. Courneya K, Friedenreich CM (1999) Physical exercise and
quality of life following cancer diagnosis: a literature review. Ann
Behav Med 21: 171–179.
15. Courneya K, Mackey JR, Jones LW (2000) Coping with cancer:
can exercise help? Phys Sportsmed 28: 49–73.
16. Courneya K (2001) Exercise interventions during cancer treat-
ment: biopsychosocial outcomes. Exerc Sport Sci Rev 29:
60–64.
17. Courneya K, Mackey JR, McKenzie DC (2002) Exercise for
breast cancer survivors: research evidence and clinical guidelines.
Phys Sportsmed 30: 33–42.
18. Sibbald B, Roland M (1998) Why are randomised controlled trials
important? BMJ 316: 201.
19. Oldervoll L, Kaasa S, Hjermstad MJ, Lund JA, Loge JH (2004)
Physical exercise results in the improved subjective well-being of a
few or is effective rehabilitation for all cancer patients? Eur
J Cancer 40: 951–962.
20. McManus R, Wilson S, Delaney BC, et al. (1998) Review of the
usefulness of contacting other experts when conducting a litera-
ture search for systematic reviews. BMJ 317: 1562–1563.
21. Blanchard C, Courneya KS, Laing D (2001) Effects of acute
exercise on state anxiety in breast cancer survivors. Oncol Nurs
Forum 28: 1617–1621.
22. Schultz I, Barholm M, Grondal S (1997) Delayed shoulder exercises
in reducing seroma frequency after modified radical mastectomy: a
prospective randomized study. Ann Surg Oncol 4: 293–297.
23. Ju
¨
ni P, Altman G, Egger M (2001) Assessing the quality of
controlled clinical trials. BMJ 323: 42–46.
24. Rosenthal R (1994) Parametric measures of effect size. In:
Cooper H, Hedges LV, eds. The Handbook of Research
Synthesis. New York: Russell Sage Foundation, pp. 231–244.
25. DerSimonian R, Laird N (1986) Meta-regression analysis in
clinical trials. Control Clin Trials 7: 177–188.
26. Sterne J, Bradburn MJ, Egger M (2001) Meta-analysis in Stata
TM
.
In: Egger M, Davey Smith G, Altman DG, eds. Systematic
Reviews in Health Care: Meta-analysis in Context. London: BMA
Books, pp. 347–369.
27. Turchetta A, Calzolari A, Donfrancesco A, Drago F, Miano C
(1990) Physical activity and competitive sport in youngs with
leukemia ’off therapy’ [abstract]. Proceedings of the World
Congress on Sport for All: Tampere, Finland.
28. Whittaker J, Baracos VE, Haennel RG, Brown BE, Humen DP
(1991) Exercise training in the posttreatment remission period of
patients with limited small cell lung cancer [abstract]. Proceedings
Exercise for cancer patients 1053
of the 24th Annual Meeting of the Canadian Association of Sport
Sciences: Kingston, Ontario.
29. Adamsen L, Rasmussen JM, Pedersen LS (2001) ’Brothers in
arms’: how men with cancer experience a sense of comradeship
through group intervention which combines physical activity with
information relay. J Clin Nurs 10: 528–537.
30. Decker W, Turner-McGlade JT, Fehir KM (1989) Psychosocial
aspects and the physiological effects of a cardiopulmonary
exercise program in patients undergoing bone marrow transplan-
tation for acute leukemia. Transplant Proc 21: 3068–3069.
31. Derman W, Coleman KL, Noakes TD (1999) Effects of exercise
training in patients with cancer who have undergone chemother-
apy [abstract]. 46th Annual Meeting of the American College of
Sports Medicine: Seattle. Med Sci Sports Exerc 31: S368.
32. Dimeo F, Bertz H, Finke J, Fetscher S, Mertelsmann R, Keul J
(1996) An aerobic exercise program for patients with haemato-
logical malignancies after bone marrow transplantation. Bone
Marrow Transplant 18: 1157–1160.
33. Dimeo F, Rumberger G, Keul J (1998) Aerobic exercise as
therapy for cancer fatigue. Med Sci Sports Exerc 30:
475–478.
34. Durak E, Lilly PC (1998) The application of an exercise and
wellness program for cancer patients: a preliminary outcomes
report. J Strength Cond Res 6: 3–6.
35. Durak E, Lilly PC (1999) A 5 year follow-up survey on health and
exercise habits in women breast cancer survivors [abstract]. 2nd
Annual Meeting of the American Society of Exercise Physiolo-
gists: Albuquerque. Breast Cancer Res Treat 57: 92.
36. Durak E, Lilly PC, Hackworth JL (1999) Physical and psychosocial
responses to exercise in cancer patients: a two year follow-up survey
with postate, leukemia and general carcinoma. J Exerc Physiol
Online (http://www.css.edu/users/tboone2/asep/jan12b.htm. Ac-
cessed Oct 30, 2002).
37. Gaskin T, LoBuglio A, Kelly P, Doss M, Pizitz N (1989)
STRETCH: a rehabilitative program for patients with breast
cancer. South Med J 82: 467–469.
38. Kolden G, Strauman TJ, Ward A, et al. (2002) A pilot study of
group exercise training (GET) for women with primary breast
cancer: feasibility and health benefits. Psychooncology 11:
447–456.
39. Kramer MM (1996) The effects of exercise on psychological well-
being in women recovering from breast cancer [abstract]. Diss
Abstr Int 57: 2157.
40. Loetzerich H, Peters C, Niemeier B, Schule K, Hoff HG,
Uhlenbruck G (1994) Influence of endurance training on natural
cytotoxicity and behaviour in cancer patients. Psychologische-
Beitraege 36: 47–52.
41. Peters C, Lotzerich H, Niemeier B, Schule K, Uhlenbruck G
(1995) Exercise, cancer and the immune response of monocytes.
Anticancer Res 15 : 175–180.
42. Peters C, Lotzerich H, Niemeier B, Schule K, Uhlenbruck G
(1994) Influence of a moderate exercise training on natural killer
cytotoxicity and personality traits in cancer patients. Anticancer
Res 14: 1033–1036.
43. Peters C (1992) Ausdauersport als Rehabilitationsmassnahme in
der Krebsnachsorge: Immunologishce und Psychologische As-
pekte [dissertation]. Ko
¨
ln: Deutschen Sporthochschule.
44. Porock D, Kristjanson L, Tinnelly K, Duke T, Blight J (2000) An
exercise intervention for advanced cancer patients experiencing
fatigue: a pilot study. J Palliat Care 16: 30–36.
45. Schulz K, Szlovak C, Schulz H, et al. (1998) Implementation
and evaluation of an exercise rehabilitation training for breast
cancer patients [German]. Psychother Psychosom Med Psychol
48: 398–407.
46. Schwartz A (1998) The relationship of exercise to fatigue and
quality of life in women with breast cancer [dissertation]. Salt
Lake City: University of Utah.
47. Schwartz AL (2000) Exercise and weight gain in breast cancer
patients receiving chemotherapy. Cancer Pract 8: 231–237.
48. Schwartz AL, Mori M, Gao R, Nail LM, King ME (2001)
Exercise reduces daily fatigue in women with breast cancer
receiving chemotherapy. Med Sci Sports Exerc 33: 718–723.
49. Schwartz AL (1999) Fatigue mediates the effects of exercise on
quality of life. Qual Life Res 8: 529–538.
50. Schwartz AL (2000) Daily fatigue patterns and effect of exercise in
women with breast cancer. Cancer Pract 8: 16–24.
51. Sharkey A, Carey AB, Heise CT, Barber G (1993) Cardiac
rehabilitation after cancer therapy in children and young adults.
Am J Cardiol 71: 1488–1490.
52. Segal R, Reid R, Johnson D, et al. (1996) Pilot study of physical
fitness and quality of life in patients with breast cancer [abstract].
32nd Annual Meeting of the American Society of Clinical
Oncology: Philadelphia, Pennsylvania.
53. Yoshioka H (1994) Rehabilitation for the terminal cancer patient.
Am J Phys Med Rehabil 73: 199–206.
54. Shore S, Shepard RJ (1999) Immune responses to exercise in
children treated for cancer. J Sports Med Phys Fitness 39: 240–
243.
55. Earle C, Reid B, Johnson D (1996) Exercise may ameliate the
effects of adjuvant breast cancer treatment on physical fitness and
quality of life [abstract]. Clin Invest Med 19: 417.
56. Segal R, Reid B, Johnson D (1996) Effects of exercise on body
composition in breast cancer patients receiving adjuvant therapy
[abstract]. Clin Invest Med 19: 426.
57. Segal R, Reid B, Johnson D (1997) Progressive resistance exercise
training in men with advanced prostate cancer [abstract]. Clin
Invest Med 20: S58.
58. Segal R, Evans WK, Gayton J, Woodard S, Wells G, Reid, R
(2000) Structured exercise improves physical functioning in
women with breast cancer (BC): results of a randomized con-
trolled trial [abstract]. Breast Cancer Res Treat 64: 128.
59. Segar M, Katch VL, Roth RS, et al. (1995) Aerobic exercise
reduces depression and anxiety, and increases self-esteem among
breast cancer survivors [abstract]. Med Sci Sports Exer 27: S212.
60. Seifert E, Ewert S, Werle J (1992) Physical training in the aftercare
of patients with cancer of the head and neck [German]. Rehabil-
itation (Stuttg) 31: 33–37.
61. Durak E, Lilly PC (1999) Preliminary results of exercise in breast
cancer: a two year follow up survey. J Rehabil Outcomes Meas 3:
53–60.
62. Lazowski DA, Ecclestone NA, Myers AM, et al. (1999) A
randomized outcome evaluation of group exercise programs in
long-term care institutions. J Gerontol 54: M621–M628.
63. Pfalzer L (1990) The responses of bone marrow transplant
patients to graded exercise testing prior to transplant and after
transplant with and without exercise training [dissertation].
Columbus: Ohio State University.
64. Schwartz AL, Thompson JA, Masood N (2002) Interferon-
induced fatigue in patients with melanoma: a pilot study of
exercise and methylphenidate. Oncol Nurs Forum 29: E85–
E90.
65. Petersson LM, Berglund G, Brodin O, Glimelius B, Sjoden PO
(2000) Group rehabilitation for cancer patients: satisfaction and
perceived benefits. Patient Educ Couns 40: 219–229.
1054 C. Stevinson et al.
66. Mock V, Pickett M, Ropka ME, et al. (2001) Fatigue and quality
of life outcomes of exercise during cancer treatment. Cancer Pract
9: 119–127.
67. Campbell A, Mutrie N, White F, McGuire F, Kearney N (2004) A
pilot study of a supervised group exercise program as a rehabil-
itation treatment for women with breat cancer receiving adjuvant
treatment. Eur J Oncol Nurs (in press).
68. Courneya K, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS
(2003) Randomized controlled trial of exercise training in post-
menopausal breast cancer survivors: cardiopulmonary and quality
of life outcomes. J Clin Oncol 21: 1660–1668.
69. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR
(2003) Effects of exercise training on fasting insulin, insulin
resistance, insulin-like growth factors, and insulin-like growth
factor binding proteins in postmenopausal breast cancer survivors:
a randomized controlled trial. Cancer Epidemiol Biomarkers Prev
12: 721–727.
70. Drouin J (2002) Aerobic exercise training effects on physical
function, fatigue and mood, immune status, and oxidative stress
in subjects undergoing radiation treatment for breast cancer
[dissertation]. Detroit: Wayne State University.
71. Galantino ML, Capito L, Kane RJ, Ottey N, Switzer S, Packel L
(2003) The effects of Tai Chi and walking on fatigue and body
mass index in women living with breast cancer: a pilot study.
Rehabil Oncol 21: 17–22.
72. Segal R, Evans W, Johnson D, et al. (2001) Structured exercise
improves physical functioning in women with stages I and II
breast cancer: results of a randomized controlled trial. J Clin
Oncol 19: 657–665.
73. Segar ML, Katch VL, Roth RS, et al. (1998) The effect of aerobic
exercise on self-esteem and depressive and anxiety symptoms
among breast cancer survivors. Oncol Nurs Forum 25: 107–113.
74. Mock V, Dow KH, Meares CJ, et al. (1997) Effects of exercise on
fatigue, physical functioning, and emotional distress during radi-
ation therapy for breast cancer. Oncol Nurs Forum 24: 991–1000.
75. Nieman DC, Cook VD, Henson DA, et al. (1995) Moderate
exercise training and natural killer cell cytotoxic activity in breast
cancer patients. Int J Sports Med 16: 334–337.
76. Mock V, Burke MB, Sheehan P, et al. (1994) A nursing
rehabilitation program for women with breast cancer receiving
adjuvant chemotherapy. Oncol Nurs Forum 21: 899–907.
77. MacVicar MG, Winningham ML, Nickel JL (1989) Effects of
aerobic interval training on cancer patients’ functional capacity.
Nurs Res 38: 348–351.
78. Winningham ML, MacVicar MG, Bondoc M, Anderson JI,
Minton JP (1989) Effect of aerobic exercise on body weight and
composition in patients with breast cancer on adjuvant chemo-
therapy. Oncol Nurs Forum 16: 683–689.
79. Winningham ML, MacVicar MG (1988) The effect of aerobic
exercise on patient reports of nausea. Oncol Nurs Forum 15:
447–450.
80. MacVicar M, Winningham, ML (1986) Promoting the functional
capacity of cancer patients. Cancer Bull 38: 235–239.
81. Winningham M (1983) Effects of a bicycle ergometry program on
functional capacity and feelings of control in women with breast
cancer [dissertation]. Columbus: Ohio State University.
82. Oliver S (2003) Physiological and psychological effects of pro-
gressive resistance training in elderly prostate cancer patients
undergoing androgen deprivation therapy: a pilot study [disser-
tation]. Bangor: University of Wales – Bangor.
83. Segal R, Reid RD, Courneya KS, et al. (2003) Resistance exercise
in men receiving androgen deprivation therapy for prostate
cancer. J Clin Oncol 21: 1653–1659.
84. Berglund G, Petersson L-M, Eriksson KRN, Ha
¨
ggman M (2003)
’Between men’: patient perceptions and priorities in a rehabilita-
tion program for men with prostate cancer. Patient Educ Couns
49: 285–292.
85. Courneya K, Friedenreich CM, Sela RA, Quinney A, Rhodes RE,
Handman M (2003) The group psychotherapy and home-based
physical exercise (GROUP-HOPE) trial in cancer survivors:
physical fitness and quality of life outcomes. Psychooncology 12:
357–374.
86. Hayes S, Davies PSW, Parker TW, Bashford J (2003) Total
energy expenditure and body composition changes following
peripheral blood stem cell transplantation and participation in an
exercise programme. Bone Marrow Transplant 31: 331–338.
87. Hayes SC, Rowbottom D, Davies PSW, Parker TW, Bashford
J (2003) Immunological changes after cancer treatment and
participation in an exercise program. Med Sci Sports Exerc 35:
2–9.
88. Hayes S, Davies PSW, Parker TW, Bashford J, Green A (2004)
The role of a mixed type, moderate intensity exercise program
following peripheral blood stem cell transplantation. Br J Sports
Med 38: 304–309.
89. Hayes S, Davies PSW, Parker TW, Bashford J, Newman B (2004)
Quality of life changes following peripheral blood stem cell
transplantation and participation in a mixed-type, moderate
intensity exercise program. Bone Marrow Transplant 33: 553–558.
90. Burnham TR, Wilcox A (2002) Effects of exercise on physiolog-
ical and psychological variables in cancer survivors. Med Sci
Sports Exerc 34: 1863–1867.
91. Mello M, Tanaka C, Dulley FL (2003) Effects of an exercise
program on muscle performance in patients undergoing allo-
geneic bone marrow transplant. Bone Marrow Transplant 32:
723–728.
92. Petersson L-M, Nordin K, Glimelius B, Brekkan E, Sjo
¨
de
´
n P-O,
Berglund G (2002) Differential effects of cancer rehabilitation
depending on diagnosis and patients cognitive coping style.
Psychosom Med 64 : 971–980.
93. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul
J (1999) Effects of physical activity on the fatigue and
psychologic status of cancer patients during chemotherapy.
Cancer 85: 2273–2277.
94. Niesen-Vertommen S (1999) The recovery patterns and effects of
exercise rehabilitation on the physiological and psychological
health of children who have survived treatment for a malignancy
[dissertation]. Vancouver: University of British Columbia.
95. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul
J (1997) Aerobic exercise in the rehabilitation of cancer patients
after high-dose chemotherapy and autologous peripheral stem cell
transplantation. Cancer 79: 1717–1722.
96. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J (1997)
Effects of aerobic exercise on the physical performance and
incidence of treatment-related complications after high-dose
chemotherapy. Blood 90: 3390–3394.
97. Berglund G, Bolund C, Gustavsson U-L, Sjoden P-O (1994) A
randomized study of a rehabilitation program for cancer patients:
the ‘starting again’ group. Psychooncology 3: 109–120.
98. Berglund G, Bolund C, Gustafsson UL, Sjoden PO (1994) One-year
follow-up of the ‘Starting Again’ group rehabilitation programme
for cancer patients. Eur J Cancer 30: 1744–1751.
99. Berglund G, Bolund C, Gustavsson UL, Sjoden PO (1993)
Starting again – a comparison study of a group of rehabilitation
program for cancer patients. Acta Oncol 32: 15–21.
100. Buettner L, Gavon SJ (1981) Personality changes and physiolog-
ical effects of a personalized fitness enrichment program for
Exercise for cancer patients 1055
cancer patients [dissertation]. Bowling Green: Bowling Green
State University.
101. Courneya K, Friendenreich CM, Quinney HA, Fields ALA,
Jones LW, Fairey AS (2003) A randomised trial of exercise
and quality of life in colorectal cancer survivors. Eur J Cancer
Care 12: 347–357.
102. Coleman E, Hall-Barrow J, Coon S, Stewart CB (2003) Facili-
tating exercise adherence for patients with multiple myeloma. Clin
J Oncol Nurs 7: 529–535.
103. Coleman E, Coon S, Hall-Barrow J, Richards K, Gaylor D,
Stewart CB (2003) Feasibility of exercise during treatment for
multiple myeloma. Cancer Nurs 26: 410–419.
104. Wall LM (2000) Changes in hope and power in lung cancer
patients who exercise. Nurs Sci Q 13: 234–242.
105. Na YM, Kim MY, Kim YK, Ha YR, Yoon DS (2000) Exercise
therapy effect on natural killer cell cytotoxic activity in stomach
cancer patients after curative surgery. Arch Phys Med Rehabil 81:
777–779.
106. Cunningham BA, Morris G, Cheney CL, Buergel N, Aker SN,
Lenssen P (1986) Effects of resistive exercise on skeletal muscle in
marrow transplant recipients receiving total parenteral nutrition.
J Parenter Enteral Nutr 10: 558–563.
107. Egger M, Dickersin K, Davey Smith G (2001) Problems and
limitations in conducting systematic reviews. In: Egger M, Davey
Smith G, Altman DG, eds. Systematic Reviews in Health Care:
Meta-analysis in Context, 2nd edn. London: BMJ Publishing
Group, pp. 43–68.
108. Easterbrook P, Berlin JA, Gopalan R, Matthews DR (1991)
Publication bias in clinical research. Lancet 337: 867–872.
109. Ioannidis JPA (1998) Effect of the statistical signficance of results
on the time to completion and publication of randomized efficacy
trials. JAMA 279: 281–286.
110. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler
C, Antes G (1997) Language bias in randomised controlled trials
published in English and German. Lancet 350: 326–329.
111. Nieminen P, Isohanni M (1999) Bias against European journals in
medical publication databases. Lancet 353: 1592.
112. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical
evidence of bias: dimensions of methodological quality associated
with estimates of treatment effects in controlled trials. JAMA 273:
408–412.
113. Moher D, Pham B, Jones A, et al. (1998) Does quality of reports
of randomised trials affect estimates of intervention efficacy
reported in meta-analyses? Lancet 352: 609–613.
114. Hollis S, Campbell F (1999) What is meant by intention to treat
analysis? Survey of published randomised controlled trials. BMJ
319: 670–674.
115. Moore R, Gavaghan D, Tramer MR, Collins SL, McQuay HJ
(1998) Size is everything – large amounts of information are
needed to overcome random effects in estimating direction and
magnitude of treatment effects. Pain 78: 209–216.
116. Bland J, Altman DG (1995) Multiple significance tests: the
Bonferroni method. BMJ 310: 170–172.
117. Smith D G, Clemens J, Crede W, Harvey M, Gracely EJ (1987)
Impact of multiple comparisons in randomized clinical trials. Am
JMed83: 545–550.
118. Dimeo F (2001) Effects of exercise on cancer-related fatigue.
Cancer 92: 1689–1693.
119. Alderson P, Roberts I (2000) Should journals publish systematic
reviews that find no evidence to guide practice? Examples from
injury research. BMJ 320 : 376–377.
120. Campbell M, Fitzpatrick, R, Haines, A, et al. (2000) Framework
for design and evaluation of complex interventions to improve
health. BMJ 321: 694–696.
1056 C. Stevinson et al.